Intrarenal IFN-γ mRNA expression differentiates clinical and subclinical glomerulitis in renal transplant recipients

Transplantation

Volumn 92, Issue 2, 2011, Pages 170-175

  Buob, David ^a,e   Hazan, Marc ^a   Homs, Sebastien ^b   Matignon, Marie ^b   Mansour, Hicham ^b   Audard, Vincent ^b   Desvaux, Dominique ^b   Remy, Philippe ^b   Noel, Christian ^a   Bastuji Garin, Sylvie ^c   Cohen, José ^d   Lang, Philippe ^b   Grimbert, Philippe ^b,d  

^a UNIV LILLE   (France)

^b INSERM   (France)

^c Laboratoire d'Investigation Clinique   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Humoral rejection; T cell phenotype glomerulitis

Indexed keywords

GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 17; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; GENE EXPRESSION; GLOMERULITIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SUBCLINICAL GLOMERULITIS; TH1 CELL; TH17 CELL; TH2 CELL;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLOMERULONEPHRITIS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; KIDNEY; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TRANSPLANTATION;

EID: 79960318297     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821eab65     Document Type: Article

References (17)

1. Solez K, Colvin RB, Racusen LC, et al. Banff07 classification ofrenal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
2. Colvin RB. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046.
3. Magil AB. Infiltrating cell types in transplant glomerulitis: Relation-ship to peritubular capillary C4d deposition. Am J Kidney Dis 2005; 45: 1084.
4. Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005; 68: 1866.
5. Cosio FG, Gloor JM, Sethi S, et al. Transplant glomerulopathy. Am J Transplant 2008; 8: 492.
6. Gloor JM, Cosio FG, Rea DJ, et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidneytransplantation. Am J Transplant 2006; 6: 1841.
7. Haas M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correla-tion with histologic findings. Am J Transplant 2006; 6: 1829.
8. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome ofsubclin-ical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561.
9. Bestard O, Cruzado JM, Rama I, et al. Presence of Fox P3 + regulatory T cells predicts outcome of subclinical rejection ofrenal allografts. J Am Soc Nephrol 2008; 19: 2020.
10. Hoffmann SC, Hale DA, Kleiner DE, et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5: 573.
11. Rowshani AT, Florquin S, Bemelman F, et al. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: A potential mech-anism for stable renal function in patients with subclinical rejection. Kidney Int 2004;66: 1417.
12. Saint-Mezard P, Berthier CC, Zhang H, et al. Analysis ofindependent microarray datasets ofrenal biopsies identifies a robust transcript sig-nature ofacute allograft rejection. Transpl Int 2009; 22: 293.
13. Sui W, Dai Y, Huang Y, et al. Microarrayanalysisofmicro RNAexpression in acute rejection after renal transplantation. Transpl Immunol 2008; 19:81.
14. Mantel PY, Kuipers H, Boyman O, et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 2007; 5: e329.
15. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokinesbut spares Th2. J Exp Med 1995; 181: 1869.
16. Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995; 80: 707.
17. Waaga-Gasser AM, Grimm MR, Lutz J, et al. Regulatory allospecific T cell clones abrogate chronic allograft rejection. J Am Soc Nephrol 2009; 20:820.